ClearPoint Neuro Inc vs PubMatic Inc — how do they compare? ClearPoint Neuro Inc trades at $15.7 (market cap $478.63M), while PubMatic Inc trades at $13.52 (market cap $635.81M). The key difference: PubMatic Inc is the larger of the two by market cap, and PubMatic Inc is trading nearer its 52-week high, ClearPoint Neuro Inc nearer its low. Which is the better fit depends on your goals.
| CLPT | PUBM | |
|---|---|---|
Market Cap | $478.63M | $635.81M |
Sector | Health | Technology |
52-Week High | $29.60 | $13.83 |
52-Week Low | $8.66 | $6.28 |
Enterprise Value | $506.63M | $533.31M |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
PubMatic trades at $13.57, up 0.15% with a bullish technical signal from moving averages. The company reported Q1 2026 earnings that beat expectations despite a net loss, with revenue of $282.93M in 2025 and a gross margin of 63.22%. Recent news highlights partnerships expanding AI-driven ad tech in CTV and international markets, supporting growth initiatives.
Outlook is mixed with strong analyst buy ratings (50%) and a $17.00 consensus target offering 25% upside, but profitability concerns persist with negative net margins and high P/E of 132. Key risks include competitive pressures and reliance on digital ad spending cycles, requiring monitoring of earnings turnaround progress.
Trailing returns across standard periods
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →PubMatic Inc is engaged in the digital advertising business. The company provides a specialized cloud infrastructure platform that enables real-time programmatic advertising transactions. The platform helps independent app developers and publishers to control and maximize their digital advertising businesses.
Read more on PUBM →